Evidence map›Paper›PMID 40730717›Full record

ArticleThe EMBO journal2025

ATXN3 regulates lysosome regeneration after damage by targeting K48-K63-branched ubiquitin chains.

Maike Reinders, Bojana Kravic, Pinki Gahlot, Sandra Koska, Johannes van den Boom, Nina Schulze, Sophie Levantovsky, Stefan Kleine, Markus Kaiser, Yogesh Kulathu and 2 more

Abstract read
In one paragraph

Article in The EMBO journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Maike Reinders *Molecular Biology I, Center of Medical Biotechnology, Faculty of Biology, University of Duisburg-Essen, Essen, Germany.ORCID http://orcid.org/0000-0002-4425-3494
Bojana Kravic *Molecular Biology I, Center of Medical Biotechnology, Faculty of Biology, University of Duisburg-Essen, Essen, Germany.
Pinki GahlotMolecular Biology I, Center of Medical Biotechnology, Faculty of Biology, University of Duisburg-Essen, Essen, Germany.ORCID http://orcid.org/0009-0000-8175-045X
Sandra KoskaMolecular Biology I, Center of Medical Biotechnology, Faculty of Biology, University of Duisburg-Essen, Essen, Germany.
Johannes van den BoomMolecular Biology I, Center of Medical Biotechnology, Faculty of Biology, University of Duisburg-Essen, Essen, Germany.ORCID http://orcid.org/0000-0002-2075-9351
Nina SchulzeImaging Center Campus Essen, Center of Medical Biotechnology, Faculty of Biology, University of Duisburg-Essen, Essen, Germany.ORCID http://orcid.org/0009-0008-5503-6218
Sophie LevantovskyMunich Cluster for Systems Neurology, Medical Faculty, Ludwig-Maximilians-Universität München, Munich, Germany.ORCID http://orcid.org/0000-0002-0918-6871
Stefan KleineChemical Biology, Center of Medical Biotechnology, Faculty of Biology, University of Duisburg-Essen, Essen, Germany.
Markus KaiserChemical Biology, Center of Medical Biotechnology, Faculty of Biology, University of Duisburg-Essen, Essen, Germany.
Yogesh KulathuMRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee, UK.ORCID http://orcid.org/0000-0002-3274-1642
Christian BehrendsMunich Cluster for Systems Neurology, Medical Faculty, Ludwig-Maximilians-Universität München, Munich, Germany.ORCID http://orcid.org/0000-0002-9184-7607
Hemmo MeyerMolecular Biology I, Center of Medical Biotechnology, Faculty of Biology, University of Duisburg-Essen, Essen, Germany. hemmo.meyer@uni-due.de.ORCID http://orcid.org/0000-0003-1883-1796

Funding

Deutsche Forschungsgemeinschaft (DFG) 259130777Deutsche Forschungsgemeinschaft (DFG) 390857198Deutsche Forschungsgemeinschaft (DFG) 424228829Deutsche Forschungsgemeinschaft (DFG) 447112704EC | European Research Council (ERC) 101002428UKRI | MRC | Medical Research Council Centre for Medical Mycology (MRC CMM) MC_UU_00038/3
6 · The paper itself

Abstract

The cellular response to lysosomal damage involves fine-tuned mechanisms of membrane repair, lysosome regeneration and lysophagy, but how these different processes are coordinated is unclear. Here we show in human cells that the deubiquitinating enzyme ATXN3 helps restore integrity of the lysosomal system after damage by targeting K48-K63-branched ubiquitin chains on regenerating lysosomes. We find that ATXN3 is required for lysophagic flux after lysosomal damage but is not involved in the initial phagophore formation on terminally damaged lysosomes. Instead, ATXN3 is recruited to a distinct subset of lysosomes that are decorated with phosphatidylinositol-(4,5)-bisphosphate and that are not yet fully reacidified. There, ATXN3, along with its partner VCP/p97, targets and turns over K48-K63-branched ubiquitin conjugates. ATXN3 thus facilitates degradation of a fraction of LAMP2 via microautophagy to regenerate the lysosomal membrane and to thereby reestablish degradative capacity needed also for completion of lysophagy. Our findings identify a key role of ATXN3 in restoring lysosomal function after lysosomal membrane damage and uncover K48-K63-branched ubiquitin chain-regulated regeneration as a critical element of the lysosomal damage stress response.

Indexed as

Ataxin-3LysosomesRepressor ProteinsUbiquitinAutophagyHEK293 CellsHeLa CellsHumansLysosomal-Associated Membrane Protein 2Ataxin-3ATXN3 protein, humanLysosomal-Associated Membrane Protein 2Repressor ProteinsUbiquitinAutophagyLysosomeMembraneStress ResponseUbiquitin

Identifiers

PMID40730717
PMCPMC12436607

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.